Edwards Reverses Course, Falling On A Mixed Third-Quarter Report
In this article:
Edwards Lifesciences stock briefly popped — and then slipped — on its mixed third-quarter report after wrapping up a key divestiture.
Advertisement
Some parts of this page are not supported on your current browser version. Please upgrade to a recent browser version.
Edwards Lifesciences stock briefly popped — and then slipped — on its mixed third-quarter report after wrapping up a key divestiture.